European Patent for Kava-Derived Therapeutic Compounds and Methods of Use Thereof
Summary
EPO granted patent EP3068416A1 to Kuality Herbceutics LLC and 9 named inventors for kava-derived therapeutic compounds and methods of use. The invention is classified under IPC codes A61K 31/12, A61K 31/353, A61K 31/366 (therapeutic compounds) and A61P 35/00 (cancer treatment). The patent is designated in 36 European states including Germany, France, UK, Italy, Spain, Netherlands, Belgium, Austria, and Switzerland.
What changed
EPO published European patent application EP3068416A1 for kava-derived therapeutic compounds and methods of use. The patent covers compounds classified under A61K 31/12, A61K 31/353, and A61K 31/366, with therapeutic application for cancer treatment (A61P 35/00). Kuality Herbceutics LLC and 9 individual inventors are named as applicants and inventors.
This patent grant affects pharmaceutical and biotech companies engaged in cancer therapeutic development or botanical compound research. Parties should conduct freedom-to-operate analyses for any overlapping compound development, explore potential licensing opportunities, and verify geographic market coverage against the 36 designated European states.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
KAVA DERIVED THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
Publication EP3068416A1 Kind: A1 Apr 08, 2026
Applicants
Kuality Herbceutics LLC, Xing, Chengguo, Hecht, Stephen, Lu, Junxuan, Upadhyaya, Pramod, Murphy, Sharon, Leitzman, Pablo, Narayanapillai, Sreekanth, Balbo, Silvia
Inventors
XING, Chengguo, HECHT, Stephen, LU, Junxuan, UPADHYAYA, Pramod, MURPHY, Sharon, LEITZMAN, Pablo, NARAYANAPILLAI, Sreekanth, BALBO, Silvia
IPC Classifications
A61K 36/67 20060101AFI20170630BHEP A61K 36/00 20060101ALI20170630BHEP A61P 35/00 20060101ALI20170630BHEP A61K 31/12 20060101ALI20170630BHEP A61K 31/353 20060101ALI20170630BHEP A61K 31/366 20060101ALI20170630BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.